Promise, Profit, and Power: Toward a Just and Equitable Future for Psychedelic Medicine
Alexander Belser, Ph.D., is a licensed psychologist and clinical supervisor at Yale University. He conducts clinical research on psychedelic-assisted psychotherapy as a treatment for anxiety, depression, alcohol abuse, and post-traumatic stress. He is the Co-Investigator of two studies at Yale exploring psilocybin-assisted psychotherapy to treat OCD and depression. Alex was a founding member of the psychedelic research team at NYU in 2006, and his research has been featured on the front page of the New York Times, in the Atlantic, the New Yorker, The Guardian, and in Michael Pollan's book, How to Change Your Mind. As a clinician, Alex sees patients with trauma as a study therapist in the Phase 3 trial of MDMA-assisted psychotherapy as a treatment for PTSD. Alex has published a dozen peer-reviewed articles and book chapters. He received a bachelor’s degree from Georgetown University, a Master of Philosophy (M.Phil.) degree from Cambridge University, and later studied clinical psychology at Columbia University and NYU. Alex completed his clinical and research training in psychology at Bellevue Hospital, New York Psychiatric Institute at Columbia University Medical Center, and Mount Sinai Beth Israel Hospital in New York His writing is available at http://alexbelser.com, and his private practice site is http://centerforbreakthroughs.com.